Effects and Safety of Metronidazole in Patients With Gastrectomy
Status:
Withdrawn
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
Recent study showed that SIBO is common among postgastrectomy patients and It appears to be
associated with postprandial intestinal symptoms and might aggravate late hypoglycemia. SIBO
could be a new therapeutic target for managing intestinal symptoms in postgastrectomy
patients.The purpose of this study is to determine whether antiboitic (metronidazole) is
effective in patients with postgasrectomy syndrome